January 2, 2026 · Form 4 insider transaction
Malzahn Craig sold 1,238 shares of REGENXBIO Inc. at $14.40 per share, a transaction worth $17.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, and January 2, 2024. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025.